[go: up one dir, main page]

HK1192488A - 用作治疗法布瑞氏症的给药方案 - Google Patents

用作治疗法布瑞氏症的给药方案 Download PDF

Info

Publication number
HK1192488A
HK1192488A HK14105931.5A HK14105931A HK1192488A HK 1192488 A HK1192488 A HK 1192488A HK 14105931 A HK14105931 A HK 14105931A HK 1192488 A HK1192488 A HK 1192488A
Authority
HK
Hong Kong
Prior art keywords
treatment
dosing regimens
fabry disease
fabry
disease
Prior art date
Application number
HK14105931.5A
Other languages
English (en)
Inventor
Stuart Greene Douglas
Joseph Valenzano Kenneth
Original Assignee
Amicus Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amicus Therapeutics, Inc. filed Critical Amicus Therapeutics, Inc.
Publication of HK1192488A publication Critical patent/HK1192488A/zh

Links

HK14105931.5A 2011-03-11 2012-03-08 用作治疗法布瑞氏症的给药方案 HK1192488A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61/451,798 2011-03-11
US61/578,201 2011-12-20
US61/596,165 2012-02-07

Publications (1)

Publication Number Publication Date
HK1192488A true HK1192488A (zh) 2014-08-22

Family

ID=

Similar Documents

Publication Publication Date Title
ZA201306735B (en) Dosing regimens for the treatment of fabry disease
LTPA2020510I1 (lt) Pakeistieji 4-fenil-piridinai, skirti su NK-receptoriumi susijusių ligų gydymui
ZA201403795B (en) Formulations for the treatment of diabetes
SMT202100136T1 (it) Regimi posologici per il trattamento della malattia di pompe
EP2673286A1 (en) Therapeutic compounds
IL229254A0 (en) Therapeutic antibodies
EP2776441A4 (en) TREATMENT METHOD WITH MULTIPLE PHARMACEUTICAL AGENTS
EP2704712A4 (en) ISOXAZOLINES AS THERAPEUTIC AGENTS
GB201112922D0 (en) Micro-organ
ZA201306613B (en) Combinations comprising macitentan for the treatment of glioblastoma multiforme
EP2700429A4 (en) DRUG SOLUTION APPLICATOR
EP2670437A2 (en) Dosing for treatment with anti-egfl7 antibodies
IL234796B (en) Compounds for the treatment of diseases related to ischemia-reperfusion
HK1192488A (zh) 用作治疗法布瑞氏症的给药方案
IL232294B (en) Preparations for the treatment of diabetes
GB201106981D0 (en) Compounds for the treatment of clostridium difficle-associated disease
HK1189818A (zh) 用於治疗多形性胶质母细胞瘤的含马西替坦的合剂
GB201106972D0 (en) Compounds for the treatment of clostridium difficile-associated disease
GB201106970D0 (en) Compounds for the treatment of clostridium difficile-associated disease
HK1194690A (zh) 作為治療劑的異噁唑啉類化合物
IL228973A (en) Oxymetazoline for the treatment of rectal disorders
AU2011903358A0 (en) Treatment
ZA201308992B (en) Therapeutic antibodies
GB201110895D0 (en) Therapeutic use
AU336805S (en) Biscuits